Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Cancer science

Showing results (1281-1290 of 6,943) with videos related to

Pageof 695
Sort By:
Cancer Science|May 22, 2026
Blocking SETD2 Enhances the Therapeutic Efficiency of Menin Inhibitor in MLL-Fusion LeukemiaAnpei Li, Yuan Zhang, Ziwei Li, et al.
Cancer Science|May 24, 2026
Tumor-Derived Extracellular Vesicles in Plasma for Predicting Anti-PD-1 Antibody Efficacy in Non-Small Cell Lung CancerTomonari Kinoshita, Shigeki Ohta, Seiki Wakui, et al.
Cancer Science|May 24, 2026
MiR-375 in CAFs-Derived EVs Promotes HCC Progression via Regulating RASA1 and May Potentially Serve as a Biomarker for HCCWei Qin, Li Wang, Beiyuan Hu, et al.
Cancer Science|May 21, 2026
Spatial Transcriptomics and Bulk RNA-Seq Analysis Revealed Molecular Classification of Invasive Lobular CarcinomaMomoko Tokura, Jun Nakayama, Hironori Suzuki, et al.
Cancer Science|May 21, 2026
Neutrophil-Macrophage Interactions Shape Inflammatory Macrophage Remodeling in Gastric Cancer During Chemo-ImmunotherapyKeita H Nagaoka, Hiroki Yamashita, Chiaki Mashima, et al.
Cancer Science|May 21, 2026
A cDC1-NK/T-Malignant Cell Circuit Drives Immunogenic Remodeling Under PD-1 Blockade in Gastric CancerTakuya Nakatsuru, Hiroki Yamashita, Chiaki Mashima, et al.
Cancer Science|May 27, 2026
MTAP Deficiency as a Metabolic Vulnerability in Cancer: Implications for Synthetic Lethal TherapyHiroaki Ikushima, Hidenori Kage
Cancer Science|May 24, 2026
Mutational Signature-Based Biomarker for Phase II Trial of Olaparib Maintenance in Advanced High-Grade Ovarian CancerKatsutoshi Oda, Daisuke Shintani, Akira Nishijima, et al.
Cancer Science|May 27, 2026
UBE2C-Mediated CD147-CTLA-4 Axis Promotes T Cell Exhaustion and Immunosuppressive Microenvironment in Bladder CancerXuwei Hong, Ting Hong, Xinyu Liu, et al.
Cancer Science|May 27, 2026
Evolving Pathology of Anaplastic Thyroid Carcinoma: Integrating Morphology, Immunohistochemistry, and Molecular InsightsToru Odate, Tetsuo Kondo
Pageof 695

Showing results (1281-1290 of 6,943) with videos related to

Sort By:
Pageof 695
Cancer Science|May 22, 2026
Blocking SETD2 Enhances the Therapeutic Efficiency of Menin Inhibitor in MLL-Fusion LeukemiaAnpei Li, Yuan Zhang, Ziwei Li, et al.
Cancer Science|May 24, 2026
Tumor-Derived Extracellular Vesicles in Plasma for Predicting Anti-PD-1 Antibody Efficacy in Non-Small Cell Lung CancerTomonari Kinoshita, Shigeki Ohta, Seiki Wakui, et al.
Cancer Science|May 24, 2026
MiR-375 in CAFs-Derived EVs Promotes HCC Progression via Regulating RASA1 and May Potentially Serve as a Biomarker for HCCWei Qin, Li Wang, Beiyuan Hu, et al.
Cancer Science|May 21, 2026
Spatial Transcriptomics and Bulk RNA-Seq Analysis Revealed Molecular Classification of Invasive Lobular CarcinomaMomoko Tokura, Jun Nakayama, Hironori Suzuki, et al.
Cancer Science|May 21, 2026
Neutrophil-Macrophage Interactions Shape Inflammatory Macrophage Remodeling in Gastric Cancer During Chemo-ImmunotherapyKeita H Nagaoka, Hiroki Yamashita, Chiaki Mashima, et al.
Cancer Science|May 21, 2026
A cDC1-NK/T-Malignant Cell Circuit Drives Immunogenic Remodeling Under PD-1 Blockade in Gastric CancerTakuya Nakatsuru, Hiroki Yamashita, Chiaki Mashima, et al.
Cancer Science|May 27, 2026
MTAP Deficiency as a Metabolic Vulnerability in Cancer: Implications for Synthetic Lethal TherapyHiroaki Ikushima, Hidenori Kage
Cancer Science|May 24, 2026
Mutational Signature-Based Biomarker for Phase II Trial of Olaparib Maintenance in Advanced High-Grade Ovarian CancerKatsutoshi Oda, Daisuke Shintani, Akira Nishijima, et al.
Cancer Science|May 27, 2026
UBE2C-Mediated CD147-CTLA-4 Axis Promotes T Cell Exhaustion and Immunosuppressive Microenvironment in Bladder CancerXuwei Hong, Ting Hong, Xinyu Liu, et al.
Cancer Science|May 27, 2026
Evolving Pathology of Anaplastic Thyroid Carcinoma: Integrating Morphology, Immunohistochemistry, and Molecular InsightsToru Odate, Tetsuo Kondo
Pageof 695